Document Detail


How well do medicinal chemists learn from experience?
MedLine Citation:
PMID:  21704183     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
To an outsider, the exploration of thousands of molecules to find a small number of potential candidate drugs must appear enormously wasteful, but many medicinal chemists would defend this waste as unavoidable. Here, I provide evidence that suggests that modern medicinal chemists are overproductive in that they synthesise many more compounds than are required to achieve the objectives of the project. The difficulties encountered in finding the data for the analysis presented here prompted the design and implementation of a more rigorous approach to capture the essence of a medicinal chemistry program. The result, medicinal chemistry knowledge sharing (MeCKS), was designed to capture and communicate emerging issues and their solutions to the medicinal chemistry community.
Authors:
David R Cheshire
Related Documents :
22117933 - Herbal medicine use among urban residents in lagos, nigeria.
15141853 - Terrorism, disasters, and security.
19454133 - The inhaled pin inaccessible to the bronchoscope: a management conundrum.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-15
Journal Detail:
Title:  Drug discovery today     Volume:  -     ISSN:  1878-5832     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9604391     Medline TA:  Drug Discov Today     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Affiliation:
Department of Chemistry, AstraZeneca Charnwood, Bakewell Road, Loughborough, LE11 5RH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Truncated HER2: implications for HER2-targeted therapeutics.
Next Document:  Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and...